
ASSAY Clinical Research: Developing Tailor-made Software Solutions & Tools with Nonpareil Quality & Efficiency


Sudharshan M. Chandran
Managing Director
Since its establishment in 2012, ASSAY has carved its niche to outshine in strategic planning,
process development or restructuring the framework, rescue studies, recruitment strategy and project management for phase I to IV clinical trials. Discerning the importance of resources in the clients’ business space, its Strategic Resourcing team called 'V-Share’ built with extensive database proffers consulting and the right resources regardless of size/scope of their work. Besides planning and implementing risk management strategies & measures to enhance quality as per the scenario/study, it also engages in additional site and CRA quality assessment visits to countries posed with highest risks/concerns assuring that the risk factors are eliminated and a strong CAPA is built. Moreover, while utilizing offshore teams in India for any study in data management and pharma covigilance, it also develops academic programs leveraging the state-of-the-art 3D animated visuals through its 'ASSAY Academy' program for aspiring science/medical professionals.
Imbibing the nuances in technological trends, ASSAY has designed a fleet of tailor-made softwares and tools which includes GRAVITY (document management), PROMPT (electronic patient-reported outcome system),
Twist of TechnologiesWith the aid of an adept in-house IT team, ASSAY ensures that these softwares and tools are built on a robust, user-friendly, efficient and innovative platform adorned with intuitive, customized and reliable systems in tune with the latest technology
Imbibing the nuances in technological trends, ASSAY has designed a fleet of tailor-made softwares and tools which includes GRAVITY (document management), PROMPT (electronic patient-reported outcome system),
CREATIVE (interactive study portal), UNITE (robust Clinical Trial Management System), STAR (e-Feasibility Management System), GAIN (Learning Management System), SPACE (Time & Invoice Management System) and ASSAY Apps. With the aid of an adept in-house IT team, ASSAY ensures that these softwares and tools are built on a robust, user-friendly, efficient and innovative platform adorned with intuitive, customized and reliable systems in tune with the latest technology.
Adhering to national & international regulations for each clinical trial and agencies like US FDA, MHRA, DCGI & ICH-GCP, ASSAY also deploys pharma covigilance teams with medical monitors to monitor patient data and safety management systems to identify potential safety issues/risks. Infused with Assay’s prime goal ‘Quality and Efficiency’. Its 70+ employees are updated with latest trends & technologies via sharing of websites, group discussions and formal training sessions. Eventually, besides re-monitoring the data for a Phase III rescue study of Fabry Disease, ASSAY has covered the sub-Saharan region for exploring clinical trials and also provided free-of-cost training programs in West Africa to mould the naive into clinical research professionals.
Relishing a revenue growth of 35 percent in 2017, ASSAY has revamped its business development strategies, increased its client base and upholds innovative softwares & projects, thereby envisioning higher revenue in 2018. Also by seamlessly updating all its services in tandem with the client feedbacks and user experiences, it is currently focused on developing the requisite software systems & tools for its patient-centric software ‘PROMPT’.
Adhering to national & international regulations for each clinical trial and agencies like US FDA, MHRA, DCGI & ICH-GCP, ASSAY also deploys pharma covigilance teams with medical monitors to monitor patient data and safety management systems to identify potential safety issues/risks. Infused with Assay’s prime goal ‘Quality and Efficiency’. Its 70+ employees are updated with latest trends & technologies via sharing of websites, group discussions and formal training sessions. Eventually, besides re-monitoring the data for a Phase III rescue study of Fabry Disease, ASSAY has covered the sub-Saharan region for exploring clinical trials and also provided free-of-cost training programs in West Africa to mould the naive into clinical research professionals.
Relishing a revenue growth of 35 percent in 2017, ASSAY has revamped its business development strategies, increased its client base and upholds innovative softwares & projects, thereby envisioning higher revenue in 2018. Also by seamlessly updating all its services in tandem with the client feedbacks and user experiences, it is currently focused on developing the requisite software systems & tools for its patient-centric software ‘PROMPT’.